These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 17403408

  • 1. Natriuretic peptides and hemodynamics in preeclampsia.
    Tihtonen KM, Kööbi T, Vuolteenaho O, Huhtala HS, Uotila JT.
    Am J Obstet Gynecol; 2007 Apr; 196(4):328.e1-7. PubMed ID: 17403408
    [Abstract] [Full Text] [Related]

  • 2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hemodynamic adaptation during pregnancy in chronic hypertension.
    Tihtonen K, Kööbi T, Huhtala H, Uotila J.
    Hypertens Pregnancy; 2007 Nov 13; 26(3):315-28. PubMed ID: 17710580
    [Abstract] [Full Text] [Related]

  • 7. Prognostic merit of N-terminal-proBNP and N-terminal-proANP in mechanically ventilated critically ill patients.
    Berdal JE, Stavem K, Omland T, Hall C, Smith-Erichssen N.
    Acta Anaesthesiol Scand; 2008 Oct 13; 52(9):1265-72. PubMed ID: 18823467
    [Abstract] [Full Text] [Related]

  • 8. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
    Kouloubinis A, Kaklamanis L, Ziras N, Sofroniadou S, Makaritsis K, Adamopoulos S, Revela I, Athanasiou A, Mavroudis D, Georgoulias V.
    Int J Cardiol; 2007 Nov 30; 122(3):195-201. PubMed ID: 17289172
    [Abstract] [Full Text] [Related]

  • 9. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients.
    Ilea M, Zdrenghea D, Bodisz G, Mălai A, Gheorghiu L, Predescu D, Beudean M, Ossian V, Gligor E, Vlad C, Pop D, Bogdan E, Roşu R.
    Rom J Intern Med; 2008 Nov 30; 46(1):63-8. PubMed ID: 19157272
    [Abstract] [Full Text] [Related]

  • 10. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U, Brueckmann M, Bertsch T, Wiessner M, Liebetrau C, Lang S, Haase KK, Borggrefe M, Huhle G.
    Clin Lab; 2005 Nov 30; 51(7-8):373-9. PubMed ID: 16122147
    [Abstract] [Full Text] [Related]

  • 11. The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy.
    Kale A, Kale E, Yalinkaya A, Akdeniz N, Canoruç N.
    J Perinat Med; 2005 Nov 30; 33(2):121-4. PubMed ID: 15843261
    [Abstract] [Full Text] [Related]

  • 12. Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
    Melander O, Frandsen E, Magnusson M, Grubb A, Jovinge S, Groop L.
    J Intern Med; 2005 Mar 30; 257(3):281-8. PubMed ID: 15715685
    [Abstract] [Full Text] [Related]

  • 13. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.
    J Am Coll Cardiol; 2009 May 12; 53(19):1783-90. PubMed ID: 19422985
    [Abstract] [Full Text] [Related]

  • 14. Natriuretic peptide fragments as possible biochemical markers of hypertension in the elderly.
    Cappellin E, Gatti R, Antonelli G, Soldà G, Ragazzi E, De Palo EF, Spinella P.
    J Cardiovasc Med (Hagerstown); 2013 Apr 12; 14(4):308-13. PubMed ID: 22498997
    [Abstract] [Full Text] [Related]

  • 15. N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension.
    Partanen N, Husso M, Vuolteenaho O, Sipola P, Ruskoaho H, Peuhkurinen K, Magga J.
    J Hum Hypertens; 2011 Dec 12; 25(12):746-51. PubMed ID: 21248782
    [Abstract] [Full Text] [Related]

  • 16. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H, Chen DQ, Wang Y, Li M.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug 12; 28(9):1740-2. PubMed ID: 18819908
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 18. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber S, Kahan A.
    Arthritis Rheum; 2008 Jan 15; 58(1):284-91. PubMed ID: 18163505
    [Abstract] [Full Text] [Related]

  • 19. NT-proBNP is increased in healthy pregnancies compared to non-pregnant controls.
    Franz MB, Andreas M, Schiessl B, Zeisler H, Neubauer A, Kastl SP, Hess G, Rhomberg F, Zdunek D, Maurer G, Schlembach D, Heinze G, Szekeres T, Gottsauner-Wolf M.
    Acta Obstet Gynecol Scand; 2009 Jan 15; 88(2):234-7. PubMed ID: 19096946
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.